BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2320877)

  • 1. [Practical application of local corticotherapy: topical corticosteroids].
    Francès C
    Rev Prat; 1990 Feb; 40(6):527-30. PubMed ID: 2320877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of topical corticosteroids.
    Piérard GE; Piérard-Franchimont C; Ben Mosbah T; Arrese Estrada J
    Acta Derm Venereol Suppl (Stockh); 1989; 151():26-30; discussion 47-52. PubMed ID: 2624063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing topical corticosteroids.
    Ference JD; Last AR
    Am Fam Physician; 2009 Jan; 79(2):135-40. PubMed ID: 19178066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous mast cell depletion results from topical corticosteroid usage.
    Lavker RM; Schechter NM
    J Immunol; 1985 Oct; 135(4):2368-73. PubMed ID: 4031494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and abuse of topical corticosteroids in infections of the skin and related structures.
    Wong VK; Della Croce C; Schonfeld S; Mastrangelo AM; Lebwohl M
    J Drugs Dermatol; 2003 Jun; 2(3):268-76. PubMed ID: 12848111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory adrenal steroids that neither inhibit skin collagen synthesis nor cause dermal atrophy.
    DiPetrillo T; Lee H; Cutroneo KR
    Arch Dermatol; 1984 Jul; 120(7):878-83. PubMed ID: 6547287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for future topical glucocorticoid development.
    Brattsand R; Särnstrand B
    Acta Derm Venereol Suppl (Stockh); 1989; 151():37-46; discussion 47-52. PubMed ID: 2624065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.
    Faurschou A; Wulf HC
    Arch Dermatol; 2008 May; 144(5):620-4. PubMed ID: 18490588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histology of skin changes caused by external corticoid preparations].
    Altmeyer P
    Hautarzt; 1977 Feb; 28(2):83-8. PubMed ID: 403157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
    Koch EM; Ott R; Koehler CO
    Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical corticosteroids: mechanisms of action.
    Kragballe K
    Acta Derm Venereol Suppl (Stockh); 1989; 151():7-10; discussion 47-52. PubMed ID: 2533778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-experimental testing for anti-inflammatory activity of external corticosteroids].
    Böttger E; Koch E; Tronnier H
    Berufsdermatosen; 1977 Apr; 25(2):53-62. PubMed ID: 869888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical corticosteroids in dermatology.
    Tadicherla S; Ross K; Shenefelt PD; Fenske NA
    J Drugs Dermatol; 2009 Dec; 8(12):1093-105. PubMed ID: 20027937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroids in psoriasis: strategies for improving safety.
    Horn EJ; Domm S; Katz HI; Lebwohl M; Mrowietz U; Kragballe K;
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):119-24. PubMed ID: 20175860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The position not the presence of the halogen in corticosteroids influences potency and side effects.
    Bikowski J; Pillai R; Shroot B
    J Drugs Dermatol; 2006 Feb; 5(2):125-30. PubMed ID: 16485880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of patients' satisfaction in using potent topical corticosteroid preparations.
    Shibata Y; Ikeda H; Kihira K
    Hiroshima J Med Sci; 2007 Dec; 56(3-4):33-9. PubMed ID: 18516932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical steroid allergy and dependence.
    Prescrire Int; 2005 Feb; 14(75):21-2. PubMed ID: 15751172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.